High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants
Year: 1994
Type: article
Study design: Clinical Trial
Source: Blood
Institution: University of Arkansas for Medical Sciences
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: refractory multiple myeloma, high-dose therapy, melphalan, autologous bone marrow transplantation, peripheral blood stem cells, GM-CSF, total body irradiation, thiotepa, beta2-microglobulin, prognostic factors, event-free survival, overall survival, neutropenia, growth factor therapy, supportive care
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2418260674
